Product

The Human Cytomegalovirus Real Time PCR Kit is an in vitro assay designed to detect and quantify CMV DNA in human urine and serum on compatible multiplex real-time fluorescence analyzers. Its workflow incorporates an internal control to monitor DNA extraction and amplification, alongside four quantitative reference standards. This assay assists qualified professionals in diagnosing and managing CMV-associated conditionsincluding congenital infection, hepatitis, pneumonia, and mononucleosis-

Epstein-Barr virus (EBV), also known as human herpesvirus 4, is a member of the herpes virus family. The EBV infection prevalence in children under 4 years of age is as high as over 90%. Children infected with EBV mainly present with non-neoplastic conditions, including infectious mononucleosis (IM), chronic active EBV infection (CAEBV), EBV associated hemophagocytic lymphohistiocytosis (EBV-HLH), and X-linked lymphoproliferative syndrome (XLP). EBV is classified as a group 1 carcinogen by the

Bacteria called group BStreptococcus(group B strep, GBS) cause GBS disease. GBS bacteriacommonly live in peoples gastrointestinal and genital tracts which usually are not harmful. Babies can be exposed to GBS bacteria during delivery. Group B Streptococcusis a leading cause of neonatal and infant sepsis and meningitis globally. It is associated with maternal sepsis, stillbirths, and preterm births, and can cause disease in immunocompromised adults and the elderly, but the highest incidence

Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in SMN1 (encoding survival motor neuron protein (SMN)). SMN1is primarily responsible for making survival motor neuron (SMN) protein, which is required for maintaining normal, motor neuron function. Without enough SMN protein, motor neurons will degenerate, causing progressive loss of controlled muscle movement.Typically, the earlier the onset of the disease, the more severe the symptoms. Without early detection a

The Fetal Fibronectin (fFN) Rapid Test Kit is a membrane-based immunochromatographic fetal fibronectin testfor the qualitative detection of fFN in vaginal secretion samples from pregnant women. It is intended for professional use as an aid in the assessment of preterm birth risk. Qualitative fFN detection: Detects fetal fibronectin in vaginal secretion specimens. Rapid result: Provides a result within 15 minutes. Simple procedure: Uses a three-step testing workflow. Built-in quality co